Baidu
map

Blood:整合素α9在动脉血栓形成调控中的潜在作用

2020-01-23 QQY MedSci原创

中心点:髓系特异性整合素α9通过增强NETosis调控动脉血栓形成。摘要:证据表明中性粒细胞可通过多种机制促进血栓形成,包括中性粒细胞胞外陷阱(NETs)形成。整合素α9β1是一种在中性粒细胞中高表达的分子(与单核细胞相比)。在中性粒细胞激活时,整合素α9β1的亲和力增强,与激活的内皮细胞稳定地结合。整合素α9在动脉血栓形成中的作用尚未完全明确。Dhanesha等人建立了一种新型的髓细胞特异性的整

中心点:

髓系特异性整合素α9通过增强NETosis调控动脉血栓形成。

摘要:

证据表明中性粒细胞可通过多种机制促进血栓形成,包括中性粒细胞胞外陷阱(NETs)形成。整合素α9β1是一种在中性粒细胞中高表达的分子(与单核细胞相比)。在中性粒细胞激活时,整合素α9β1的亲和力增强,与激活的内皮细胞稳定地结合。整合素α9在动脉血栓形成中的作用尚未完全明确。

Dhanesha等人建立了一种新型的髓细胞特异性的整合素α9缺陷型小鼠(α9fl/flLysMCre+),来研究整合素α9在动脉血栓形成中的作用。α9fl/fl小鼠作对照。

研究结果显示,α9fl/flLysMCre+小鼠不太容易发生氯化三铁(FeCl3)和激光损伤所诱导的动脉血栓形成,而且止血能力无明显改变。α9fl/flLysMCre+小鼠的中性粒细胞弹性蛋白酶阳性细胞的数量显著减少,同时伴随FeCl3损伤诱导的颈动脉血栓中的中性粒细胞计数、髓过氧化物酶(MPO)水平和红细胞数量减少。

a9fl/flLysMCre+小鼠的中性粒细胞经血小板活化后,NETs释放网的百分比明显降低。此外,研究人员还发现a9fl/flLysMCre+小鼠中性粒细胞介导的血小板聚集和组织蛋白酶-G分泌明显减少。

给a9fl/flLysMCre+小鼠输注α9fl/fl中性粒细胞可恢复类似于α9fl/fl小鼠的血栓形成。用抗整合素α9抗体治疗野生型小鼠可抑制动脉血栓形成。

本研究揭示了整合素α9在调控动脉血栓形成中的潜在作用。

原始出处:

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1709013, encodeId=a63c1e09013c9, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Tue Dec 08 11:58:00 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988695, encodeId=5883198869516, content=<a href='/topic/show?id=ca9c5e8163a' target=_blank style='color:#2F92EE;'>#整合素α9#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57816, encryptionId=ca9c5e8163a, topicName=整合素α9)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Sun Jan 26 10:58:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459474, encodeId=1a9a14594e4b9, content=<a href='/topic/show?id=210e5e814f2' target=_blank style='color:#2F92EE;'>#整合素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57814, encryptionId=210e5e814f2, topicName=整合素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536826, encodeId=86d2153682609, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560178, encodeId=2b6315601e8ac, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566187, encodeId=9a52156618e01, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Fri Jan 24 15:58:00 CST 2020, time=2020-01-24, status=1, ipAttribution=)]

相关资讯

Blood:一种鉴定动脉血栓形成和出血相关基因的综合方法

中心点:一种综合方法,对参与小鼠动脉血栓形成同时有无影响止血的431个基因的功能进行比较。血栓形成/止血的蛋白质互作网络表明小鼠和人类具有高度相似性,同时鉴别出多个候选蛋白。摘要:抗血栓治疗通过预防动脉血栓形成和血栓栓塞来减少心血管疾病,但同时会增加出血风险。采用转基因小鼠进行动脉血栓研究可有效鉴别新的分子靶点。由于样本量少、研究方法多异,限制了对单基因缺陷小鼠的研究进行正式的Meta分析。为克服

Baidu
map
Baidu
map
Baidu
map